Cross-source evidence timeline

Peginesatide research timeline

Follow 34 selected, directly cited source records from October 24, 2011 through November 9, 2026. This timeline joins source lanes for navigation; it does not infer that one record confirms another.

34Selected records
10Source years
3Evidence lanes
November 9, 2026Latest source date

Source year

2026

4 records
  1. Literature metadata

    Peginesatide acetate, axitinib, and pertuzumab.↗

    PubMed lists PMID 23023854 in Journal of the American Pharmacists Association : JAPhA as Journal Article, Review, with publication-date metadata of 2012 Sep-Oct (source-text precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  2. Literature metadata

    Peginesatide in patients with anemia undergoing hemodialysis.↗

    PubMed lists PMID 23343061 in The New England journal of medicine as Clinical Trial, Phase III, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, and 1 more PubMed publication type, with publication-date metadata of 2013-01-24 (day precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  3. Literature metadata

    Peginesatide for anemia in patients with chronic kidney disease not receiving dialysis.↗

    PubMed lists PMID 23343062 in The New England journal of medicine as Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2013-01-24 (day precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  4. Literature metadata

    Peginesatide (Omontys) for anemia in chronic kidney failure.↗

    PubMed lists PMID 22683926 in The Medical letter on drugs and therapeutics as Journal Article, with publication-date metadata of 2012-06-11 (day precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

Source year

2021

3 records
  1. Literature metadata

    Peginesatide for maintenance treatment of anemia in hemodialysis and nondialysis patients previously treated with darbepoetin alfa.↗

    PubMed lists PMID 23243269 in Clinical journal of the American Society of Nephrology : CJASN as Clinical Trial, Comparative Study, Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't, with publication-date metadata of 2012-12-14 (day precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  2. Literature metadata

    Managing dialysis patients who develop anemia caused by chronic kidney disease: focus on peginesatide.↗

    PubMed lists PMID 24023516 in International journal of nanomedicine as Journal Article, Review, with publication-date metadata of 2013-08-26 (day precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  3. Literature metadata

    Peginesatide to Manage Anemia in Chronic Kidney Disease Patients on Peritoneal Dialysis.↗

    PubMed lists PMID 24584613 in Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis as Clinical Trial, Clinical Trial, Phase II, Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't, with publication-date metadata of 2014-03-01 (day precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

Source year

2019

3 records
  1. Literature metadata

    Development and validation of a mass spectrometric detection method of peginesatide in dried blood spots for sports drug testing.↗

    PubMed lists PMID 22592927 in Analytical and bioanalytical chemistry as Journal Article, Research Support, Non-U.S. Gov't, Validation Study, with publication-date metadata of 2012-05-17 (day precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  2. Clinical trials

    ClinicalTrials.gov record NCT00314795↗

    PeptideScanner retained ClinicalTrials.gov record NCT00314795 at 2026-11-16T17:45:11.119Z. Its registry update date was 2019-03-14, and PeptideScanner's reviewed identity mapping was peginesatide.↗

  3. Regulatory

    Federal Register notice 2019-02146↗

    The Federal Register published notice 2019-02146, attributed to FDA and its parent HHS department, on 2019-02-13. Its official title is “Takeda Pharmaceuticals U.S.A., Inc.; Withdrawal of Approval of a New Drug Application for OMONTYS (peginesatide) Injection,” and PeptideScanner's exact reviewed identity mapping connects the document to Peginesatide.↗

Source year

2018

5 records
  1. Literature metadata

    Peginesatide for anemia in chronic kidney disease.↗

    PubMed lists PMID 23594010 in The New England journal of medicine as Letter, Comment, with publication-date metadata of 2013-04-18 (day precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  2. Literature metadata

    Peginesatide for anemia in chronic kidney disease.↗

    PubMed lists PMID 23594011 in The New England journal of medicine as Letter, Comment, with publication-date metadata of 2013-04-18 (day precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  3. Literature metadata

    On peginesatide and anemia treatment in CKD.↗

    PubMed lists PMID 23810692 in American journal of kidney diseases : the official journal of the National Kidney Foundation as Editorial, Comment, with publication-date metadata of 2013-06-28 (day precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  4. Literature metadata

    Peginesatide for the treatment of anemia in the nephrology setting.↗

    PubMed lists PMID 22745925 in Drugs of today (Barcelona, Spain : 1998) as Journal Article, with publication-date metadata of 2012-06 (month precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  5. Literature metadata

    Peginesatide for the treatment of anemia due to chronic kidney disease - an unfulfilled promise.↗

    PubMed lists PMID 27551882 in Expert opinion on drug safety as Comparative Study, Journal Article, Review, with publication-date metadata of 2016-08-23 (day precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

Source year

2017

3 records
  1. Literature metadata

    Methods for detection and confirmation of Hematide™/peginesatide in anti-doping samples.↗

    PubMed lists PMID 21816551 in Forensic science international as Journal Article, with publication-date metadata of 2011-08-03 (day precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  2. Literature metadata

    Peginesatide as a new approach for treating anemia of CKD patient: is it like a falling star?↗

    PubMed lists PMID 23675762 in Expert opinion on pharmacotherapy as Editorial, with publication-date metadata of 2013-05-16 (day precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  3. Literature metadata

    Watch out for a revival of peginesatide in sports.↗

    PubMed lists PMID 27279382 in Drug testing and analysis as Journal Article, with publication-date metadata of 2016-06-09 (day precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

Source year

2016

1 record
  1. Clinical trials

    ClinicalTrials.gov record NCT01478971↗

    PeptideScanner retained ClinicalTrials.gov record NCT01478971 at 2026-11-16T17:45:11.119Z. Its registry update date was 2016-09-20, and PeptideScanner's reviewed identity mapping was peginesatide.↗

Source year

2014

1 record
  1. Regulatory

    Federal Register notice 2014-11523↗

    The Federal Register published notice 2014-11523, attributed to FDA and its parent HHS department, on 2014-05-20. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; OMONTYS,” and PeptideScanner's exact reviewed identity mapping connects the document to Peginesatide.↗

Source year

2013

4 records
  1. Clinical trials

    ClinicalTrials.gov record NCT00597584↗

    PeptideScanner retained ClinicalTrials.gov record NCT00597584 at 2026-11-16T17:45:11.119Z. Its registry update date was 2013-03-08, and PeptideScanner's reviewed identity mapping was peginesatide.↗

  2. Clinical trials

    ClinicalTrials.gov record NCT00597753↗

    PeptideScanner retained ClinicalTrials.gov record NCT00597753 at 2026-11-16T17:45:11.119Z. Its registry update date was 2013-02-12, and PeptideScanner's reviewed identity mapping was peginesatide.↗

  3. Clinical trials

    ClinicalTrials.gov record NCT00598273↗

    PeptideScanner retained ClinicalTrials.gov record NCT00598273 at 2026-11-16T17:45:11.119Z. Its registry update date was 2013-02-12, and PeptideScanner's reviewed identity mapping was peginesatide.↗

  4. Clinical trials

    ClinicalTrials.gov record NCT00598442↗

    PeptideScanner retained ClinicalTrials.gov record NCT00598442 at 2026-11-16T17:45:11.119Z. Its registry update date was 2013-02-12, and PeptideScanner's reviewed identity mapping was peginesatide.↗

Source year

2012

9 records
  1. Clinical trials

    ClinicalTrials.gov record NCT00097747↗

    PeptideScanner retained ClinicalTrials.gov record NCT00097747 at 2026-11-16T17:45:11.119Z. Its registry update date was 2012-12-21, and PeptideScanner's reviewed identity mapping was peginesatide.↗

  2. Clinical trials

    ClinicalTrials.gov record NCT00228436↗

    PeptideScanner retained ClinicalTrials.gov record NCT00228436 at 2026-11-16T17:45:11.119Z. Its registry update date was 2012-12-21, and PeptideScanner's reviewed identity mapping was peginesatide.↗

  3. Clinical trials

    ClinicalTrials.gov record NCT00228449↗

    PeptideScanner retained ClinicalTrials.gov record NCT00228449 at 2026-11-16T17:45:11.119Z. Its registry update date was 2012-12-21, and PeptideScanner's reviewed identity mapping was peginesatide.↗

  4. Clinical trials

    ClinicalTrials.gov record NCT00272662↗

    PeptideScanner retained ClinicalTrials.gov record NCT00272662 at 2026-11-16T17:45:11.119Z. Its registry update date was 2012-12-21, and PeptideScanner's reviewed identity mapping was peginesatide.↗

  5. Clinical trials

    ClinicalTrials.gov record NCT00752791↗

    PeptideScanner retained ClinicalTrials.gov record NCT00752791 at 2026-11-16T17:45:11.119Z. Its registry update date was 2012-08-15, and PeptideScanner's reviewed identity mapping was peginesatide.↗

  6. Clinical trials

    ClinicalTrials.gov record NCT00752609↗

    PeptideScanner retained ClinicalTrials.gov record NCT00752609 at 2026-11-16T17:45:11.119Z. Its registry update date was 2012-07-27, and PeptideScanner's reviewed identity mapping was peginesatide.↗

  7. Clinical trials

    ClinicalTrials.gov record NCT00434330↗

    PeptideScanner retained ClinicalTrials.gov record NCT00434330 at 2026-11-16T17:45:11.119Z. Its registry update date was 2012-06-29, and PeptideScanner's reviewed identity mapping was peginesatide.↗

  8. Clinical trials

    ClinicalTrials.gov record NCT00680043↗

    PeptideScanner retained ClinicalTrials.gov record NCT00680043 at 2026-11-16T17:45:11.119Z. Its registry update date was 2012-06-29, and PeptideScanner's reviewed identity mapping was peginesatide.↗

  9. Regulatory

    Drugs@FDA application NDA202799↗

    The official Drugs@FDA dataset lists original submission 1 for NDA 202799 with status AP dated 2012-03-27, and names peginesatide acetate among the application record's active ingredients.↗

Source year

2011

1 record
  1. Regulatory

    Federal Register notice 2011-27327↗

    The Federal Register published notice 2011-27327, attributed to FDA and its parent HHS department, on 2011-10-24. Its official title is “Oncologic Drugs Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Peginesatide.↗